Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission
Clinical trial NCT00522301 · TERMINATED
Trial details
- NCT number
- NCT00522301
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2008-03-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.